Platform Technology Partners Matinas Bio Pharma Holdings, Inc. Transaction History

Platform Technology Partners

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.12 - $0.64 $739 - $3,942	-6,160 Reduced 3.79%	156,250 $34,000
Q3 2022 Oct 24, 2022	BUY	$0.63 - $33.0 $12,600 - $660,000	20,000 Added 14.04%	162,410 $103,000
Q1 2022 May 03, 2022	SELL	$0.5 - $1.06 $9,375 - $19,875	-18,750 Reduced 11.63%	142,410 $115,000
Q4 2021 Feb 01, 2022	SELL	$0.92 - $1.22 $3,680 - $4,880	-4,000 Reduced 2.42%	161,160 $163,000
Q3 2021 Nov 04, 2021	SELL	$0.67 - $1.51 $17,420 - $39,260	-26,000 Reduced 13.6%	165,160 $215,000
Q2 2021 Aug 05, 2021	BUY	$0.75 - $1.1 $24,375 - $35,750	32,500 Added 20.48%	191,160 $148,000
Q4 2020 Feb 09, 2021	SELL	$0.76 - $1.47 $7,980 - $15,435	-10,500 Reduced 6.21%	158,660 $216,000
Q3 2020 Nov 30, 2020	BUY	$0.67 - $0.96 $16,187 - $23,193	24,160 Added 16.66%	169,160 $130,000
Q2 2020 Nov 30, 2020	BUY	$0.52 - $0.92 $23,400 - $41,400	45,000 Added 45.0%	145,000 $112,000
Q4 2019 Dec 03, 2020	BUY	$0.63 - $2.27 $63,000 - $227,000	100,000 New	100,000 $227,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

Stay updated on Platform Technology Partners with notifications on news.